| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.1M | — | +17.4% |
| R&D Expense | $900K | — | -25.4% |
| SG&A Expense | $11.0M | — | +27.1% |
| Operating Income | -$4.3M | — | +5.0% |
| Pre-tax Income | -$4.8M | — | -13.0% |
| Income Tax | -$1K | — | +0.0% |
| Net Income | -$4.8M | — | -13.1% |
| EPS (Basic) | -$0.41 | — | +12.8% |
| EPS (Diluted) | -$0.41 | — | +12.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.3M | -1.2% | +253.9% |
| Inventory | $1.2M | -13.7% | -81.1% |
| Current Assets | $13.2M | -27.2% | -14.2% |
| Total Assets | $24.8M | -13.2% | +49.4% |
| Current Liabilities | $10.9M | -8.2% | -0.3% |
| Total Liabilities | $18.7M | +3.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$70K | — | +98.3% |
| Capital Expenditures | $5K | — | +66.7% |
| Investing Cash Flow | -$5K | — | -66.7% |
| Free Cash Flow | -$75K | — | +98.2% |
| +16.1% |
| Stockholders' Equity | $6.1M | -42.1% | +1194.2% |